《大行報告》麥格理上調青啤(00168.HK)目標價至60.4元 評級「跑贏大市」
麥格理發表研究報告,將青啤(00168.HK)的投資評級由原來的「中性」上調至「跑贏大市」,這是由於股權激勵計劃理應能推動管理層進一步提高公司盈利。據媒體及渠道調查顯示,公司從5月5日起將選擇性單品的出廠價提高10%,該行認為此舉將確保今年的利潤表現,而谷底的情況已經過去。
報告指,雖然集團銷量下降,但受惠於有利的產品結構變化,今年首季的毛利率上升0.4個百分點至40.1%。該行將公司2020及2021財年盈利預測分別提升18%及22%,目標價由原來的42元上調至60.4元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.